Advanced Medical Solutions Grp PLC Director/PDMR Shareholding (0299R)

TIDMAMS

RNS Number : 0299R

Advanced Medical Solutions Grp PLC

11 June 2018

 
   11 June 2018 
 

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Director/PDMR Shareholding

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that it was notified on 6 June 2018 that Pieter van Hoof, who is a Senior Manager and PDMR, following the successful achievement of certain performance criteria, has exercised 36,375 options from the Long Term Incentive Plan (LTIP). Mr van Hoof has also, following the end of the holding period, exercised 4,643 options from the Deferred Annual Bonus Plan (DAB). Mr van Hoof elected to receive an additional 58 dividend shares which were earned during the 3 year holding period under the terms of the scheme. Mr van Hoof has also elected to exercise 13,608 Ordinary Shares of 5p from the Deferred Share Bonus Plan.

Mr van Hoof subsequently sold 61,488 Ordinary Shares of 5p each on 6 June 2018 at a share price of 330.50p per Ordinary Share. As a result of these transactions Pieter van Hoof's beneficial interest in the Company has decreased from 127,208 shares to 120,404 shares.

Long Term Incentive Plan (LTIP)

 
 PDMR          No. of         LTIPs        Ordinary   Ordinary    LTIPs 
                LTIPs prior    exercised    Shares     Shares      after 
                to exercise                 sold       retained    exercise 
------------  -------------  -----------  ---------  ----------  ---------- 
 Pieter van 
  Hoof         108,300        36,375       36,375     Nil         71,925 
------------  -------------  -----------  ---------  ----------  ---------- 
 

Deferred Annual Bonus Plan (DAB)

 
 PDMR          DABs           DABs         Dividend    Ordinary   Ordinary    DABs 
                prior          exercised    Shares      Shares     Shares      after 
                to exercise                 received    sold       retained    exercise 
------------  -------------  -----------  ----------  ---------  ----------  ---------- 
 Pieter van 
  Hoof         18,809         4,643        58          4,701      Nil         14,166 
------------  -------------  -----------  ----------  ---------  ----------  ---------- 
 

Deferred Share Bonus Plan (DSB)

 
 PDMR          No. of DSBs   DSBs exercised   Ordinary   Ordinary    DSBs after 
                prior to                       Shares     Shares      exercise 
                exercise                       sold       retained 
------------  ------------  ---------------  ---------  ----------  ----------- 
 Pieter van 
  Hoof         28,818        13,608           13,608     Nil         15,210 
------------  ------------  ---------------  ---------  ----------  ----------- 
 

Overall Holding

 
 PDMR          Holding        Number       Dividend    Number       Sale      Resultant   % of 
                prior          of shares    Shares      of shares    price     holding     issued 
                to exercise    exercised    received    sold         (p)                   share 
                                                                                           capital 
------------  -------------  -----------  ----------  -----------  --------  ----------  --------- 
 Pieter van 
  Hoof         127,208        54,626       58          61,488       330.50p   120,404     0.056% 
------------  -------------  -----------  ----------  -----------  --------  ----------  --------- 
 

The Company further announces that it was notified on 6 June 2018 that Simon Coates, who is a Senior Manager and PDMR, elected to exercise 9,518 Ordinary Shares of 5p from the Deferred Share Bonus Plan (DSB). Mr Coates subsequently sold 4,490 Ordinary Shares of 5p each on 6 June 2018 at a share price of 330.50p per Ordinary Share to cover the tax and National Insurance payable on this exercise. As a result of these transactions Simon Coates's beneficial interest in the Company has increased from 97,581 shares to 102,609 shares.

Deferred Share Bonus Plan (DSB)

 
 PDMR            No. of DSBs   DSBs exercised   Ordinary   Ordinary    DSBs after 
                  prior to                       Shares     Shares      exercise 
                  exercise                       sold       retained 
--------------  ------------  ---------------  ---------  ----------  ----------- 
 Simon Coates    39,736        9,518            4,490      Nil         30,218 
--------------  ------------  ---------------  ---------  ----------  ----------- 
 

Overall Holding

 
 PDMR            Holding        Number       Number       Number       Sale      Resultant   % of 
                  prior          of shares    of shares    of shares    price     holding     issued 
                  to exercise    exercised    sold         retained     (p)                   share 
                                                                                              capital 
--------------  -------------  -----------  -----------  -----------  --------  ----------  --------- 
 Simon Coates    97,581         9,518        4,490        5,028        330.50p   102,609     0.048% 
--------------  -------------  -----------  -----------  -----------  --------  ----------  --------- 
 

The Company further announces that it was notified on 8 June 2018 that Steve Bellamy, who is a Director and PDMR, transferred the legal ownership of his shares from ADM Investors Nominees Limited to HSBC Global Custody Nominee (UK) Limited. The number of shares held by Steve Bellamy and the beneficial ownership of the shares remains unchanged.

Overall Holding

 
 PDMR             Holding        Number       Sale     Resultant   % of issued 
                   prior          of shares    price    holding     share capital 
                   to exercise    sold         (p) 
---------------  -------------  -----------  -------  ----------  --------------- 
 Steve Bellamy    100,000        Nil          -        100,000     0.047% 
---------------  -------------  -----------  -------  ----------  --------------- 
 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  --------------------------------------------------------------- 
 a)   Name: Pieter van Hoof 
---  --------------------------------------------------------------- 
 2.   Reason for the notification 
---  --------------------------------------------------------------- 
 a)   Position/status: Senior Manager/PDMR 
---  --------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  --------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  --------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  --------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  --------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  --------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  --------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Exercise of 36,375 shares from the Long Term 
                Incentive Plan 
 
 
           *    Exercise of 4,643 shares from the Deferred Annual 
                Bonus Plan 
 
 
           *    Award of 58 Dividend Shares from the Deferred Annual 
                Bonus Plan 
 
 
           *    Exercise of 13,608 shares from the Deferred Share 
                Bonus Plan 
 
 
           *    Sale of 61,488 Ordinary Shares of 5p 
---  --------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)    Volume(s) 
       ----------  ---------- 
        GBP3.305    61,488 
       ----------  ---------- 
---  --------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: 61,488 
       Aggregated price: GBP3.305 
---  --------------------------------------------------------------- 
 e)   Date of the transaction: 06/06/2018 
---  --------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  --------------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  ----------------------------------------------------------- 
 a)   Name: Simon Coates 
---  ----------------------------------------------------------- 
 2.   Reason for the notification 
---  ----------------------------------------------------------- 
 a)   Position/status: Senior Manager/PDMR 
---  ----------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  ----------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ----------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 

       plc 
---  ----------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  ----------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ----------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  ----------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Exercise of 9,518 shares from the Deferred Share 
                Bonus Plan 
 
 
           *    Sale of 4,490 Ordinary Shares of 5p 
---  ----------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)    Volume(s) 
       ----------  ---------- 
        GBP3.305    4,490 
       ----------  ---------- 
---  ----------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: 4,490 
       Aggregated price: GBP3.305 
---  ----------------------------------------------------------- 
 e)   Date of the transaction: 06/06/2018 
---  ----------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  ----------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  ---------------------------------------------------------- 
 a)   Name: Steve Bellamy 
---  ---------------------------------------------------------- 
 2.   Reason for the notification 
---  ---------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  ---------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  ---------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ---------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  ---------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  ---------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ---------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  ---------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Transfer of legal ownership of 100,000 Ordinary 
                Shares of 5p 
---  ---------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: 
       Nil 
---  ---------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: Nil 
       Aggregated price: Nil 
---  ---------------------------------------------------------- 
 e)   Date of the transaction: 08/06/2018 
---  ---------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  ---------------------------------------------------------- 
 

-End -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group                Tel: +44 (0) 
  plc                                             1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Chief Financial 
  Officer 
 
 Consilium Strategic Communications              Tel: +44 (0) 
                                                 20 3709 5700 
 Mary-Jane Elliott / Matthew Neal     [e-mail] 
  / Nicholas Brown 
 
 Investec Bank PLC (NOMAD & Broker)              Tel: +44 (0) 
                                                 20 7597 5970 
 Daniel Adams / Patrick Robb / 
  Gary Clarence 
 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHBLGDLIGBBGIB

(END) Dow Jones Newswires

June 11, 2018 12:12 ET (16:12 GMT)